BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 25704067)

  • 1. Cost-effectiveness of "full spectrum endoscopy" colonoscopy for colorectal cancer screening.
    Hassan C; Gralnek IM
    Dig Liver Dis; 2015 May; 47(5):390-4. PubMed ID: 25704067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
    Hassan C; Zullo A; Winn S; Morini S
    Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme.
    Hassan C; Senore C; Radaelli F; De Pretis G; Sassatelli R; Arrigoni A; Manes G; Amato A; Anderloni A; Armelao F; Mondardini A; Spada C; Omazzi B; Cavina M; Miori G; Campanale C; Sereni G; Segnan N; Repici A
    Gut; 2017 Nov; 66(11):1949-1955. PubMed ID: 27507903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A resect and discard strategy would improve cost-effectiveness of colorectal cancer screening.
    Hassan C; Pickhardt PJ; Rex DK
    Clin Gastroenterol Hepatol; 2010 Oct; 8(10):865-9, 869.e1-3. PubMed ID: 20621680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.
    Hassan C; Rex DK; Cooper GS; Zullo A; Launois R; Benamouzig R
    Gut; 2012 Aug; 61(8):1172-9. PubMed ID: 21997545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
    Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
    Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists.
    Hassan C; Rex DK; Zullo A; Cooper GS
    Cancer; 2012 Sep; 118(18):4404-11. PubMed ID: 22707430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopist-directed propofol administration versus anesthesiologist assistance for colorectal cancer screening: a cost-effectiveness analysis.
    Hassan C; Rex DK; Cooper GS; Benamouzig R
    Endoscopy; 2012 May; 44(5):456-64. PubMed ID: 22531982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
    Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
    Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard forward-viewing colonoscopy versus full-spectrum endoscopy: an international, multicentre, randomised, tandem colonoscopy trial.
    Gralnek IM; Siersema PD; Halpern Z; Segol O; Melhem A; Suissa A; Santo E; Sloyer A; Fenster J; Moons LM; Dik VK; D'Agostino RB; Rex DK
    Lancet Oncol; 2014 Mar; 15(3):353-60. PubMed ID: 24560453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-generation full-spectrum endoscopy versus standard forward-viewing colonoscopy: a multicenter, randomized, tandem colonoscopy trial (J-FUSE Study).
    Kudo T; Saito Y; Ikematsu H; Hotta K; Takeuchi Y; Shimatani M; Kawakami K; Tamai N; Mori Y; Maeda Y; Yamada M; Sakamoto T; Matsuda T; Imai K; Ito S; Hamada K; Fukata N; Inoue T; Tajiri H; Yoshimura K; Ishikawa H; Kudo SE
    Gastrointest Endosc; 2018 Nov; 88(5):854-864. PubMed ID: 29908178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat colonoscopy every 10 years or single colonoscopy for colorectal neoplasm screening in average-risk Chinese: a cost-effectiveness analysis.
    Wang ZH; Gao QY; Fang JY
    Asian Pac J Cancer Prev; 2012; 13(5):1761-6. PubMed ID: 22901118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Full-spectrum Endoscopy in Colorectal Cancer Screening: Randomized Trial.
    Núñez-Rodríguez H; Diez-Redondo P; Pérez-Miranda M; Gonzalez Sagrado M; Conde R; De la Serna C
    J Clin Gastroenterol; 2019 Mar; 53(3):191-196. PubMed ID: 29283904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program.
    Brenner H; Altenhofen L; Kretschmann J; Rösch T; Pox C; Stock C; Hoffmeister M
    Gastroenterology; 2015 Aug; 149(2):356-66.e1. PubMed ID: 25911510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full spectrum endoscopy (FUSE) versus standard forward-viewing endoscope (SFV) in a high-risk population.
    Roepstorff S; Hadi SA; Rasmussen M
    Scand J Gastroenterol; 2017 Nov; 52(11):1298-1303. PubMed ID: 28799428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective cohort study evaluating a novel colonoscopy platform featuring full-spectrum endoscopy.
    Gralnek IM; Segol O; Suissa A; Siersema PD; Carr-Locke DL; Halpern Z; Santo E; Domanov S
    Endoscopy; 2013 Sep; 45(9):697-702. PubMed ID: 23939509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of artificial intelligence for screening colonoscopy: a modelling study.
    Areia M; Mori Y; Correale L; Repici A; Bretthauer M; Sharma P; Taveira F; Spadaccini M; Antonelli G; Ebigbo A; Kudo SE; Arribas J; Barua I; Kaminski MF; Messmann H; Rex DK; Dinis-Ribeiro M; Hassan C
    Lancet Digit Health; 2022 Jun; 4(6):e436-e444. PubMed ID: 35430151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.